MYMD PHARMACEUTICALS INC (MYMD)

US62856X2018 - Common Stock

2.82  -0.04 (-1.4%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2023-9-30)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
0.000.000.000.000.00
Cost Of Goods
0.000.000.000.000.00
Gross Profit
0.000.000.000.000.00
Operating Expenses
16.02M15.28M28.80M12.29M3.39M
Research and Development
7.37M9.07M6.75M7.96M0.00
Selling, General, and Administrative Expenses
7.89M6.22M21.46M4.32M3.40M
Operating Income
-16.02M-15.28M-28.80M-12.29M-3.39M
Interest Income/Expense
1.35M80.00K10.00K140.00K100.00K
Other Income/Expense
N/AN/AN/AN/AN/A
Non Recurring Items
-180.00K0.00-1.09M0.00-80.00K
Income Before Taxes
-5.39M-15.20M-29.89M-12.15M-3.38M
Income Tax
0.000.000.000.000.00
Net Income
-7.08M-15.20M-29.89M-17.58M-3.89M
EBITDA
N/AN/AN/A-12.26M-3.32M
 
Per Share Data
EPS Diluted Total Ops
-0.18-0.39-0.85-4.98-12.54
 
Statistics
Gross Profit Margin
N/AN/AN/AN/AN/A
Profit Margin
N/AN/AN/AN/AN/A
Operating Profit Margin
N/AN/AN/AN/AN/A

All data in USD

Charts